Page 25 - Contract Development News Today

Strides Pharma shareholders would receive 1 share of OneSource for every 2 shares of Strides in the swap ratio of 1:2

Strides Pharma Science on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft gelatin business into a new entity which would list in the next 12-16 months.

Demerger will be completed by April 1, 2024 according to the stock exchange filing

SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate at the RBC Capital Markets Virtual CDMO Conference. David Enloe, chief executive officer, will be the fe...

Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.

/PRNewswire/ -- The "Laboratory Automation Market - A Global Market and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and...

In today's rapidly evolving digital landscape, blockchain technology has emerged as a groundbreaking innovation with the potential to reshape industries.

Mucosal route induces both localized and systemic immunityIntravacc is currently developing 3 OMV-based intranasal vaccinesArticle published in...

The approval is for the acquisition of up to 76.1 percent stake in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.

Mabion S.A. - Directors Report for the first half of 2023 MABION S.A. Directors Report for the first half of 2023 ...